Furthermore, overexpression of SOX1 attenuated β-catenin-mediated TCF/LEF signaling via binding with β-catenin and competition for TCF/LEF binding sites in HCC[25]. This evidence concerns the gene SOX1 and hepatocellular carcinoma.